These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 3783611)
1. Inhibition of cathepsin D by substrate analogues containing statine and by analogues of pepstatin. Agarwal NS; Rich DH J Med Chem; 1986 Dec; 29(12):2519-24. PubMed ID: 3783611 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of aspartic proteases by pepstatin and 3-methylstatine derivatives of pepstatin. Evidence for collected-substrate enzyme inhibition. Rich DH; Bernatowicz MS; Agarwal NS; Kawai M; Salituro FG; Schmidt PG Biochemistry; 1985 Jun; 24(13):3165-73. PubMed ID: 3927973 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of porcine pepsin by two substrate analogues containing statine. The effect of histidine at the P2 subsite on the inhibition of aspartic proteinases. Maibaum J; Rich DH J Med Chem; 1988 Mar; 31(3):625-9. PubMed ID: 3126296 [TBL] [Abstract][Full Text] [Related]
4. Synthetic and enzyme inhibition studies of pepstatin analogues containing hydroxyethylene and ketomethylene dipeptide isosteres. Holladay MW; Salituro FG; Rich DH J Med Chem; 1987 Feb; 30(2):374-83. PubMed ID: 3100803 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of analogues of the carboxyl protease inhibitor pepstatin. Effects of structure on inhibition of pepsin and renin. Rich DH; Sun ET; Ulm E J Med Chem; 1980 Jan; 23(1):27-33. PubMed ID: 6767029 [TBL] [Abstract][Full Text] [Related]
6. Biological activity of aspartic proteinase inhibitors related to pepstatin. Gunn JM; Owens RA; Liu WS; Glover GI Acta Biol Med Ger; 1981; 40(10-11):1547-53. PubMed ID: 6805191 [TBL] [Abstract][Full Text] [Related]
7. Mode of inhibition of acid proteases by pepstatin. Marciniszyn J; Hartsuck JA; Tang J J Biol Chem; 1976 Nov; 251(22):7088-94. PubMed ID: 993206 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of the novel pi-(benzyloxymethyl)-protected histidine analogue of statine. Inhibition of penicillopepsin by pepstatin-derived peptides containing different statine side-chain derivatives. Maibaum J; Rich DH J Med Chem; 1989 Jul; 32(7):1571-6. PubMed ID: 2661819 [TBL] [Abstract][Full Text] [Related]
12. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions. Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of cathepsin D by tripeptides containing statine analogs. Bessodes M; Antonakis K; Herscovici J; Garcia M; Rochefort H; Capony F; Lelièvre Y; Scherman D Biochem Pharmacol; 1999 Jul; 58(2):329-33. PubMed ID: 10423175 [TBL] [Abstract][Full Text] [Related]
14. Investigation of the synthetic route to pepstatin analogues by SPPS using O-protected and O-unprotected statine as building blocks. Cadicamo CD; Asante V; Abu Ammar M; Borelli C; Korting HC; Koksch B J Pept Sci; 2009 Apr; 15(4):272-7. PubMed ID: 19189272 [TBL] [Abstract][Full Text] [Related]
15. Structure-Activity Relationships of JMV4463, a Vectorized Cathepsin D Inhibitor with Antiproliferative Properties: The Unique Role of the AMPA-Based Vector. Vezenkov LL; Sanchez CA; Bellet V; Martin V; Maynadier M; Bettache N; Lisowski V; Martinez J; Garcia M; Amblard M; Hernandez JF ChemMedChem; 2016 Feb; 11(3):302-8. PubMed ID: 26639308 [TBL] [Abstract][Full Text] [Related]
16. Characterization of new fluorogenic substrates for the rapid and sensitive assay of cathepsin E and cathepsin D. Yasuda Y; Kageyama T; Akamine A; Shibata M; Kominami E; Uchiyama Y; Yamamoto K J Biochem; 1999 Jun; 125(6):1137-43. PubMed ID: 10348917 [TBL] [Abstract][Full Text] [Related]
17. New renin inhibitors containing novel analogues of statine. Jones DM; Sueiras-Diaz J; Szelke M; Leckie BJ; Beattie SR; Morton J; Neidle S; Kuroda R J Pept Res; 1997 Aug; 50(2):109-21. PubMed ID: 9273895 [TBL] [Abstract][Full Text] [Related]
18. Substrate specificities of pepstatin-insensitive carboxyl proteinases from gram-negative bacteria. Ito M; Dunn BM; Oda K J Biochem; 1996 Oct; 120(4):845-50. PubMed ID: 8947851 [TBL] [Abstract][Full Text] [Related]
19. [p-Nitroanilides of amino acids and peptides and fluorescence peptide with inner fluorescence quenching as substrates for cathepsins H, B, D and high molecular weight aspartic peptidase in the brain]. Azarian AV; Agatian GL; Galoian AA Biokhimiia; 1987 Dec; 52(12):2033-7. PubMed ID: 3328984 [TBL] [Abstract][Full Text] [Related]
20. Replacement of isobutyl by trifluoromethyl in pepstatin A selectively affects inhibition of aspartic proteinases. Binkert C; Frigerio M; Jones A; Meyer S; Pesenti C; Prade L; Viani F; Zanda M Chembiochem; 2006 Jan; 7(1):181-6. PubMed ID: 16307463 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]